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Flavoridin and echistatin, isolated from the- venom of Trh,¢resuruxflararlridis and Echix ¢¢zrh~utu$. respectively. I~lonB ¢o tilt disintel;rin family 
of inttgrin p~ and 0~ inhibitors ol" low molecular w¢isht gGD.¢ontainin8, cy,qeinc.vith poptid=s. Sin= disulfide bonds ar¢ criti~l for expression 
ot" biological activity, we sought to determine their location in these two proteins. In fluvoridin, direct cvidcn=: for the exist¢n¢¢ o1. linkug~ between 
Cys'-Cy= =" and betwcgn Cys ° and Cys" was obtained by analysis of proteolyti¢ products, and indirect evidence sullg¢sts links between Cys'-Cys =+ 
and Cys~>-Cys ~. In e=histatin, links between Cys'-Cys >~ and Cys'~-Cys ~ were identified by dir=t chemical analysis, 
Inhibitor or intogrin: Disintcgrin: Disulfide bride: F.x:histatin: Flavoridin 
1, INTRODUCTION 
Disintegrins represent a nero| family of integrin ,~t 
and,6~ inhibitory proteins isolated from venoms of" var- 
ious vipers (family Viperidae) [1-4]. They interfere with 
biologicat processes such as cell adhesion to extracellu- 
far matrix, including adhesion of melanoma cells and 
fibroblasts to fibronectin [L6], and are potent inhibitors 
ofplatelet aggregation (ICu~=20-200 aM) [ I - i  1]. Anal- 
ysis of the amino acid sequences of disintegrins [1.-4, 
6-12] shows that the tripeptide, RGD, which repr~¢nts 
a cell attachment recognition sequence in a number of 
adhesiv¢ proteins It 3], has been conserved in all but one 
of these molecules. The exception is barbourin, where 
lysin¢ replacing arginine is thought to contribute to its 
int=grin 0~II~/,8~ antagonist specificity [4]. The appropri- 
ate spatial configuration of this recognition motif, de- 
termined largely by disulfide bridges, is essential for the 
inhibitor:/potency of disint=grins [3,5,7,14,15]. In a pre- 
vious study, we established the disulfide bond pattern 
in albolabrin [15]. The purpose of this study was to 
determine the location of disulfide bridges in flavoridin. 
as well as in natural and synthetic echistatin, by isola- 
tion and sequencing of proteolytic fragments. 
2, MATERIALS  AND METHODS 
Synthetic ethistutin was purchased from Uach=m Inc. (USA) and 
was used without further purification, Natural echistatin and fla. 
vuridh~ -,~,Ice. ~ by ,~,,+;.~.~b;-.,~ upLC f";6;., th'¢ l.vop!",.ili:~:~l 
Curr¢spm~dence address: J. Calvele. Institute "Rocasolano' C.S,I.C., 
C2Scrruno 119, 2S006-Madrid, Spain, Fax: (34)(I) 564 2431, 
venom of Echis cariualux and TPimerexuPuxflat~riridb (Si~u~a Chcm. 
ical Co., St, Louis. MO), r~pecl;vely, uling a Vydao Cttl column 
(H=spcria. CA) (0,44 x 25 cm. 300 A pore si=¢) and =lutinll with a 
mixture of 0,1~ (v/v) TFA in wulcr (solution A) and acetonhrilc 
(solution B), The column was first elutcd isocmtb:ally (t00% A) for 
10 rain, followed by a l iner Iradient up to ll0'~ B in SO rain. Active 
poptidcs wcr¢ idcntilicd by their ability to inhibit ADP.induced pluto- 
lot ailtre~atioa us describ~ [I$], 
Echistatin. either natural or synthetic, and flavoridin, (2 rag/m| in 
lO0 mM NH.,HCO;~. pH 8,0) wcr¢ di;~|cd with TPCK.trypsin 
(Sigma) at an ¢nxyme:substrato ratio of I:50 (w/w) for 4 h at 3"PC, 
Dil~tion ol'echistatin was stopl~.d with formic acid (final ¢omazntra. 
tion 30~ (v/v)), and the styptic popfidcs were scparut¢ by rever~e- 
phar, e HPLC on a Lichrosphcr JOe RP- l~ (S#M particle size) (Merck, 
Darmstadt) column cquilibrate.d in a mixture of O.Ig'a (v/v) TFA in 
wuttr (solution A) and in u=tonilrile (solution B) (95~ A/:~% I~) and 
¢luted at I mVmin, at ~rst isocratically for 5 rain and then followed 
by a linear gradient up to 40'~ B in 70 rain, 
Th= enzyme in the trypti¢ digest o1" flavoridin was h=at-inactivatcd 
(1,00"C t'or 5 rain), endnproteinase Asp-N (Boehrin~r.Mannhcim, 
Indianapolis. IN) was ;tddcd up to u final tnxyme:substra|c ratio o1" 
h25 (w/w) and incubated 6 h at 37'C, Thereafter, the resuhinll pep 
tides were separated ;is above. Elation conditions were: 5 rain isoerati- 
rally (100% A) followed by a linear gradient up to 30~ B in 90 rain. 
The isolated peptid¢s wore chaructedzc.d by amino acid analysis 
(after acid hydrolysis with 6 N HCI foe 24 h at 110"C using a Biotronic 
(amino acids aualyzcr) and amino-tem~inal sequence analysis (using 
an Applied Biosystcms. Sun Francisco. CA) gas-phase scquenc=r 
mod~l 473A, Mass spectra were recorded with a mats spectrometer 
MAT 900 (Finni~n MAT. Bremen. FRO) equipped with liquid s¢c- 
oudaw ion ionization system. 
3. RESULTS 
3,1. Disu~de bridge pattern of fiavorldin 
Proteolytic digestion of flavoridin with trypsin and 
endoproteinuse Asp.N gave nine lt'actions (Table I), 
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Table I 
Amino acid sequence of flavoridin ill and of p~ptidts obtained by 
reverse.phase HPLC after its diltcstion with trypsin and cndopro- 
tcinasc Asp.N 
flivoriGtn:. 
GESC~CGSI~SNPCCOAATCKLRI~.d~I'.MGLCC~.~CRFIKKRTICRINIGI~FPP~tCTGL~OCPR~ 
1 ~O |0 ]O 40 ~,0 GO 70 
F-it 30 FK 39 
47 IN! 4ti 
?O OL ?0 
F-l: 1, ~[C :) 
15 D~TCI |0 
4, 
6 
TrXl:Stn, 
Asp-H 
f-3: 36 fl~[l~ 4t 
611 ~ 69 
F-4: It kR~ 2S 
F-I: 2? CA 28 
3Z C¢ 3) 
Ii~ CTGLSIt 4) 
F-4t 43 TICR 46 
64 OCPR O? 
F-?: 59 TGLf~ 4] 
F-O: S OCGSPSHK¢ 14 
34 O~CR 37 
F-St 2| LRPG.~.J~GLC¢ ]3 
C 
Table lI 
Amino  acid sequence of ~histatin and of I~ptidcs obtained by its 
dilb'stion with TPCK.trypsin (the order o1" tome products has bcm~ 
uttered to show u degradation pathway from T-3 throuBh Tdi) 
EcMstat~n: ECESGPCCRHCgFLKEGTICKRA~GOOMDOYCHGTODPRHPHK~AT 
t I0 20 30 40 
TPCg-Tr~Sin 
T - l :  42 NPHiK 45 
46 GPAT 49 
T -2 :13  FLK 15 
T-3: I ECESGF¢¢R~¢RFLg[~|CK 21 
25 GODI~D~YCN~KTCDePR 41 
T-~: 1 ECES~CCRHCK 12 
16 EGTIOK 21 
2S GODHDDYCNGKTCDCPR 41 
T-4: I ECESGPCCR 9 
10 NC~ 12 
2S GODHDD¥CHGKTCDC~fl 41 
T-S: 1 ECESGPCOR 9 
10 NC¢ t2 
10 EGTICK 21 
25 GDD~DDYCflGK 35 
36 TCDCPR 41 
Two fractions. F-2 and F-6 (M + H" = 979.1). each 
contained two sequences in a 1: i molar ratio, indicating 
the existence of disulfide bonds between Cys 4 and Cys ~ 
in fraction F-2. and between Cys 's and Cys ~'~ in fraction 
1:'-6. On th, other hand, fractions F-S, F-8 and F-9 each 
contained four cysteine residues involved in the forma- 
tion of two disulfide bridges. Although at this stage the 
actual pairing could not be ¢stablished. the fact that a 
disulfide bond between adjacent cystein~s i  stericaily 
hindered limits to four the actual pairing possibilities. 
Thus. Cys 6 cannot be paired with Cys ~, since such a 
pairing would leave two adjacent cysteines, Cys ~ and 
Cys J', unpaired. The pairing of Cys:7-Cys ~is also for- 
bidden, since this would leave Cys ~: and Cys ~ unpaired. 
Among the remaining possibilities, bonding between 
Cysa-Cys t~. Cyst~-Cys ~, Cys~"-Cys :. and Cys~-Cys ~ 
would be consistent with the recently reported NMR 
solution structure of kistrin [16], a similar disintegrin 
[3L 
3.2. Disu~de bridge pattern of eehistatin 
The tryptic peptides of synthetic echistatin are shown 
in Table It. T-l, T-2 an T-5 were final digestion prod. 
acts. while T-3 was a partial digestion product hat gave 
riP_. to T-6, T4  ~nd T.~s in that order, Th~ esmbtish~d 
that the first cleavage sites occur at bonds Kat.-R :', 
Rn_A3~, Ra,_Gas ~41 ~4a and K4S-G ~, indicating that 
the RGD recognition motif and the C-terminal tail arc 
both readily exposed; the other bonds, KI2-F ~:, K ~s- 
EtG, R~N ~° and K~S-T ~, were presumably less acc~ssi. 
ble. The final tryptic degradation product, T-5 (Table 
II) was composed of five fragments cross.linked by four 
disulfide bonds giving ri~¢ to several possibilities for 
disulfide bridges. 
To establish the actual disulfide bridge arrangement 
in echistatin, T-5 was further degraded with elastase, 
and the resulting peptides were isolated by reverrc- 
phase HPLC. This yielded a set of successively degraded 
products from which a degradation pattern as well as 
the position of disulfide bridges could be deduced 
(Table III). On degradation of T-S/E-7 to T-S/E-6. Cys ~ 
and Cys ~9 both disappeared indicating that Cys ~ and 
Cys ~ were disulfide linked. This confirms NMR studi~s 
[17-21], Cleavage of T-f/E-5 (M + H* = 2,239.S) to 
T-5/E-4 resulted in the loss of Cy# and Cys 3~ indicating 
that they were disulfide bonded. Analysis of fragment 
T-5/E-I (M + H" = 1.31 I,I) did not show whether Cys t 
was paired to Cys" or Cys ~3, The second possibility 
would agree with recently reported tH NMR studies of 
synthetic ¢chistatin i  solution [16--20], Furthermore, an 
S--S bond between Cys" and Cys tj has been described 
[18]. The r~sonance studies could not distinguish be. 
tween the pairing possibilities Cys"-Cys37:Cys 7- Cys3~o 
and Cys~-Cys~':C:/s~-Cys~7). Our prot¢in.-chemical 
data established the Cysa.-Cys ~7 linkage, which was pre- 
viously predicted on the basis of the disulfide bridg~ 
pattern reported for albolabrin [14]. 
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Tublo !I1 
Amino acid ~quenc¢ of the di$~lion product~ or pcptid¢ T-$ by 
porcine puncti l io ¢htsias¢ (a dqlrndation pathwa), for T.5/E,~ 
throulih T.~/E. I can b¢ followed) 
T-0/E-I: ? CeR 
¢ 20 
¢ 11 or 32 
30 T~CPR 41 
T-S/E-t; 16 E;TI 19 
T-51E-3:25 GDDI~DY 31 
T-fIE-4: I ECESGP¢ 6 
10 N¢~ 12 
25 GOD.DYe 32 
contained the peptides ~ECESG s and ZSGDD- 
MDDYC ~" disulfide bridged (M + H" = 1.454.5) was 
found. Whether this pcptide resulted from limited disul- 
fide bridge rearrangement during isolation and/or deg- 
radation of the protein, or wether it reflects the existence 
of a small echiatatin population with an alternative di- 
sulfide bridge pattern (which interestingly would be sim- 
ilar to the one found in albolabrin [15]) cannot be con- 
eluded fro~ our data. Neverthel~s, computer mod- 
elling of this alternative pairing showed that it would 
not introdu~ significant changes into the conformation 
of the RGD loop. 
T-SlE-5: I ECESGPCC 6 
l0 H¢I~ 12 
25 GOOI~DX¢ 3= 
3? ¢ 
T-§IE-6: I ECES6~¢¢~ S 
10 H¢~ 12 
25 ODDMDD~¢~ 31 
36 TO0 38 
T-51E-7: I ECESGPCCR 
10 H¢~ 12 
Z0 CK 21 
2S 6O0~BYCNGg 3S 
3~ T¢0¢ 39 
T-51E-8= I ECESGPCCR¢ 9 
10 ~CK lZ 
16 ENTICE 21 
25 ~DI~OTCN~ 3S 
36 TCO¢ 39 
When natural echistatin was proteolytically degraded 
in the same way as the synthetic molecule, a very minor 
component (~timatcd to repres~t less than 5%2, which 
4. DISCUSSION 
Si:'~cc disulfide bridg~ are essential for expr~sion of 
the biological activity of disintegrins [3,4.11.13,14], we 
were interested in the disulfide brid~,c p-teems in these 
peptides. Isolation, amino acid sequencing and analysis 
of prot=olytic fragments of flavoridin ('Table 1) and 
echistatin (Tables II and III) enabled us to identify some 
disulfide bridges (Fig. 1). The disulfide brid~e pattern 
ofalbolabrin as previously described [l5] was added for 
comparison. We identified two S-S bridges in fla- 
voridin, and the other ones were du, luced. Our observa- 
tions on ~histatin confirm the location of two disulfide 
bridges (Cys-'-Cys ~ and Cys'"--Cys') previously pro- 
posed on the basis of NMR. studies [17.18]. We were 
abl= to add the location of one more (Cys'-Cys ~)) based 
on our protein chemistry data. Bond Cys~-Cys ~: was 
deduced since these were the only remaining cystcines. 
&~olab~£n 
:L :LO ~10 30 4D 50 (iO ?0 
F l&vo~n 
Lo io  =o 40 5o vo  
:1. ~LO 20  30  40  
l 
-I , ! 
.. Jl 
Fig, 1. Schematic repP..~:n|ation of' the structure of thr¢: disinte~rins, Di,~ulNd~ bonds that are conserved or scmi.co,~serv¢d are shown by double 
lines, The other bonds arc shown by ~inglc lines, 
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In flavoridin and =histatin. as well as in aibolabrin 
[15]. the disulfide bonds form a complex pattern of over- 
lapping loops and loops within loops (Tables I - I l l ,  Fig. 
1). This pattern ~tends from the first to the last cysteine 
in the pcptide, and leaves only a few N-terminal (one to 
five:) and C-terminal (six to ten) amino acids beyond 
these loops [1-5, 6-10]. In all thr~ disintogrins, two 
disulfide bridges form an interesting motif with respect 
to the RGD sequence. A domain containing the RGD 
s~uence is defined by a combination of two disulfide 
bonds, One is formed between the cysteine closest o the 
ROD sequence on the N-terminal end of the peptide 
and the last cyst¢in¢ in th¢ ixptide, This bond is highly 
conserved. The other is betw~n the cystcinc closest to 
the RGD seqaen~ on the C-terminal end of the mole. 
cule and one cysteine of the N.terminal segment, 
The formation of these two disulfide bridges has two 
comcqu¢n~s, (i) ddincation of an RGD-contaming do- 
main that has I l amino acids betw=a the cyst¢ines, and 
(ii) formation ot'a shorter (6 amino acid) segment of 
peptide that limits the distance I~twe~n the S-S bridges 
defining the RGD.containing domain (a 'retainer" see- 
meat). Obviously this arrangement throws the RGD. 
containing domain into a loop. a finding consistent with 
observations made by NMR [17-21], This motif de- 
~nds on the pres~n~ of two or more cystcincs, both 
C.terminal and N.terminal to th~ RGD sequence, and 
the formation of at least two trans-gGD disulfide 
bonds. All disiatesrins sequenced todate have two cys. 
t¢in=s C-terminal to the RGD sequence, except for 
=histatin and eristostatin which have three C-terminal 
cysteines. All scquen~d isintegrins have more than 
two cysteines N-terminal to the RGD sequence, with the 
number depending on the length of the peptide, If the 
'retainer' segm~t isable to change its length by forming 
a secondary structure, this arrangement might provide 
a means for varying the shape of the loop, thereby 
influencing the configuration of the RGD sequence and 
possibly the biological activity of the peptide. 
Elucidation of the disulfide bridge patterns of fla- 
voridin and ~histatin (Fig. l) provide information for 
revising oar previous prediction that the disulfide bond 
pattern would be the same in all disintegrins [15], It is 
noteworthy that flavoridin and kistrin [16] have identi- 
cal patterns of S-S bridges [16]. The differences between 
albolabrin compared to flavoridin and kistrin probably 
depend on differ¢nces in folding which would bring 
different cysteines within bonding distan~ of each 
other. Differences in folding patterns probably depend 
on differen=s in amino acid s~quences in the peptides. 
Three peptides with similar ability to antagonize the 
plat¢let fibrinogen r¢~ptor have been isolated from 
other sources and sequenced. They have little resem- 
tion or arrang¢ment of cysteines. Two peptidcs, d¢- 
corsin and ornatin, isolated from leeches, have only one 
cysteine C-terminal to the RGD sequence [22,23]. Thus, 
only one trans-RGD disulfide bond ~n be formed, i.¢. 
an RGD-¢ontaining loop in these ~ptidcs must be de. 
fined by one rather than two disulfide bonds. The other 
peptide, mambin, was isolated from the venom of a 
snake belonging to the family Etapidae. Mambin differs 
from l~.¢h l~pt id~ as well as disintegrins [24]. While 
mambin has three cyst¢ines C-terminal and five N-ter- 
minal to the RGD sequent, McDowell ¢t al. [24] sug- 
gested that the ROD-containing loop is defined by on= 
disulfide bond, that I>=tween Cys4~-Cys 4. The influence 
of these different patterns of disulfide bonds on the 
conformation of the RGD-containing loop and on bio- 
logical functions of the various peptides will help to 
~tablish structure-function rclationsMps. 
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